Cargando...
Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies
Recent studies in the field of cancer stem cells have revealed that the alterations in key gene products involved in the epithelial-mesenchymal transition (EMT) program, altered metabolic pathways such as enhanced glycolysis, lipogenesis and/or autophagy and treatment resistance may occur in cancer...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3938987/ https://ncbi.nlm.nih.gov/pubmed/23994756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mam.2013.08.001 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|